Cargando…

Targeted tumor therapy: turning the genome on its head

Detalles Bibliográficos
Autores principales:	Lawler, Matthew M, Dunn, Ian S, Newton, Estelle E, Rose, Lenora B, Kurnick, James T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991253/ http://dx.doi.org/10.1186/2051-1426-1-S1-P133

Ejemplares similares

Assembly of Biologically Functional Structures by Nucleic Acid Templating: Implementation of a Strategy to Overcome Inhibition by Template Excess
por: Lawler, Matthew M., et al.
Publicado: (2022)

Heat Shock Protein-90 Inhibitors Enhance Antigen Expression on Melanomas and Increase T Cell Recognition of Tumor Cells
por: Haggerty, Timothy J., et al.
Publicado: (2014)

Turning tumor inhibition into activation: engineering T cells with chimeric signaling receptors
por: Schlenker, Ramona, et al.
Publicado: (2014)

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
por: Balza, Enrica, et al.
Publicado: (2006)

Pacemakers and AICDs in the Magnet; have we turned the corner?
por: Samar, Huma, et al.
Publicado: (2016)

Anti-EGFR targeted monoclonal antibody isotype influences anti-tumor immunity in head and neck cancer patients
por: Trivedi, Sumita, et al.
Publicado: (2015)

Fluid creep in burn resuscitation: the tide has not yet turned
por: James, E, et al.
Publicado: (2012)

Radiation therapy and vaccination against tumor-specific EGFRvIII effectively clears tumors in a murine model of head and neck squamous cell carcinoma
por: Uhde, Lauren, et al.
Publicado: (2015)

Targeting uroporphyrinogen decarboxylase for head and neck cancer treatment
por: Ito, Emma, et al.
Publicado: (2013)

Assessment of the tumor immune-environment in patients with head and neck cancer
por: Feng, Zipei, et al.
Publicado: (2015)

“Road traffic incidents: an emerging epidemic and can we make an epidemic “U” turn?
por: Dilip, Sri Ramula Sai, et al.
Publicado: (2015)

Brachyury, a driver of tumor invasiveness and resistance to multiple therapies, is a novel immunotherapy target
por: Palena, Claudia, et al.
Publicado: (2013)

Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy
por: Khalil, Danny, et al.
Publicado: (2015)

Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
por: Reuben, Alexandre, et al.
Publicado: (2014)

Utilizing quantitative immunohistochemistry for relationship analysis of tumor microenvironment of head and neck cancer patients
por: Feng, Zipei, et al.
Publicado: (2014)

Dual targeting of the tumor and its associated vasculature using a single bispecific chimeric antigen receptor molecule
por: Byrd, Tiara, et al.
Publicado: (2014)

Use of magnetic resonance targeting to steer ov-loaded cell-based therapies to tumor sites in vivo
por: Muthana, Munitta, et al.
Publicado: (2015)

Treatment with the IDO inhibitor INCB024360 increased lysis of human tumor cell targets by peptide-specific CTL
por: Jochems, Caroline, et al.
Publicado: (2015)

Targeted genome reconstruction strategy for endosymbionts in eukaryotic genomes
por: Saha, Surya, et al.
Publicado: (2012)

An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers
por: Mougdil, Tarsem, et al.
Publicado: (2015)

PD-1 is a marker of activation on tumor infiltrating NK cells in head and neck cancer
por: Concha-Benavente, Fernando, et al.
Publicado: (2015)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Nowhere else to turn? building a case for equity of access to VV ECMO in the UK for complex multi-system patients
por: Loveridge, R, et al.
Publicado: (2015)

Are contouring time and multimodality imaging prognostic factors for radiation therapy of advanced head and neck cancer?
por: Eller, Y, et al.
Publicado: (2015)

Turning cell cycle entry on its head
por: Bertoli, Cosetta, et al.
Publicado: (2014)

Head-to-head comparison of myocardial perfusion SPECT and CMR for assessment of myocardial ischemia
por: Hedeer, Fredrik, et al.
Publicado: (2015)

Turning up the adenosine turns off the spleen
por: Walkden, Michelle, et al.
Publicado: (2015)

PD-L1 is preferentially expressed on CD44+ tumor-initiating cells in head and neck squamous cell carcinoma
por: Lee, Yunqin, et al.
Publicado: (2014)

Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
por: Wu, Tc, et al.
Publicado: (2013)

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment
por: Pedersen, Sara R, et al.
Publicado: (2015)

Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015)

Identification of drug targets for the treatment of Basal-like tumors
por: Hoadley, KA, et al.
Publicado: (2005)

Targeting the tumor vasculature with TEM8-specific T cells
por: Williams, LaTerrica C, et al.
Publicado: (2014)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment
por: Kosmides, Alyssa K, et al.
Publicado: (2014)

Targeting YAP-dependent MDSC infiltration impairs tumor progression
por: Wang, Guocan, et al.
Publicado: (2015)

Vaccine-induced tumor regression requires a multi-step cooperation between T cells and myeloid cells at the tumor site
por: Thoreau, Maxime, et al.
Publicado: (2015)

Anti-tumor effects of anti-PD-L1 therapy in an orthotopic bladder tumor model
por: Lyon, Amanda, et al.
Publicado: (2014)

Turning a fasthug [1] into low flat hugs could improve compliance with daily care bundles on the general intensive care unit: a preliminary audit
por: Brooke, M, et al.
Publicado: (2015)

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission
por: Goh, J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b2ts7542kgmf6uu219qag0smgs